Structure-based drug design for new therapies for Leishmaniasis and Chagas disease (2024)
Source: Acta Crystallographica. Section A: Foundations and Advances. Conference titles: European Crystallography Meeting. Unidade: ICB
Subjects: PARASITOLOGIA, PROTOZOA, ANTIPARASITÁRIOS, LEISHMANIA, AMINOÁCIDOS, DOENÇA DE CHAGAS
ABNT
POHL, Ehmke et al. Structure-based drug design for new therapies for Leishmaniasis and Chagas disease. Acta Crystallographica. Section A: Foundations and Advances, v. 80, 2024Tradução . . Disponível em: https://doi.org/10.1107/S2053273324099194. Acesso em: 27 nov. 2025.APA
Pohl, E., Silber, A. M., Pohl, S. F., & Sowerby, K. (2024). Structure-based drug design for new therapies for Leishmaniasis and Chagas disease. Acta Crystallographica. Section A: Foundations and Advances, 80. doi:10.1107/S2053273324099194NLM
Pohl E, Silber AM, Pohl SF, Sowerby K. Structure-based drug design for new therapies for Leishmaniasis and Chagas disease [Internet]. Acta Crystallographica. Section A: Foundations and Advances. 2024 ; 80[citado 2025 nov. 27 ] Available from: https://doi.org/10.1107/S2053273324099194Vancouver
Pohl E, Silber AM, Pohl SF, Sowerby K. Structure-based drug design for new therapies for Leishmaniasis and Chagas disease [Internet]. Acta Crystallographica. Section A: Foundations and Advances. 2024 ; 80[citado 2025 nov. 27 ] Available from: https://doi.org/10.1107/S2053273324099194
